Tg.rasH2 mouse (27-week, completed) and SD rat (2-year, ongoing)
“The carcinogenicity assessment for donidalorsen includes a completed 27-week study in Tg.rasH2 mice and a 2-year study in SD rats that is ongoing with the final report due in Q4 2025.”
Yes: mouse surrogate ISIS 722059 in mouse toxicity studies to assess on-target effects
“Donidalorsen does not align perfectly to the mouse PKK gene sequence, so the mouse toxicity studies also evaluated mouse surrogate ISIS 722059 to assess on-target effects.”